ency rates
than bare-metal stents (BMSs) in AIOD, particularly in the
more advanced lesions. However, in a more recent singlecenter, retrospective study, BMSs had superior patency to
covered stents at 1 year.158 Regardless of any potential patency
advantages, covered stents may provide a safety margin in the
treatment of calciÔ¨Åed common iliac lesions or ectatic vessels
where rupture is a distinct possibility